🔎 Trials Near Me

Hem › Akut myeloid leukemi › Oregon › Portland

Kliniska studier för Akut myeloid leukemi i Portland, OR

25 studier för Akut myeloid leukemi söker deltagare vid platser i och runt Portland (inom ca 30 miles). Öppna en studie för att se vem som kan delta och hur du kontaktar studieteamet.

Officiell studietext (engelska)

Rekryterar du till en studie? Visa den högst upp på sidan – $99 i 30 dagar →

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

RekryterarFas 2
  • Providence Portland Medical Center, Portland
  • Providence Saint Vincent Medical Center, Portland
Ålder 18 och äldre · Alla kön · Uppdaterad 5 okt. 2026 · NCT05564390

Ruxolitinib With Azacitidine Maintenance for the Treatment of Patients With Acute Myeloid Leukemia Undergoing Reduced Intensity Allogeneic Stem Cell Transplantation

RekryterarFas 1
  • OHSU Knight Cancer Institute, Portland
Ålder 18 och äldre · Alla kön · Uppdaterad 5 okt. 2026 · NCT07548983

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

RekryterarObservationsstudieFriska volontärer välkomna
  • Providence Portland Medical Center, Portland
  • Providence Saint Vincent Medical Center, Portland
  • Providence Willamette Falls Medical Center, Oregon City · 12 mi bort
Ålder 40 till 75 · Alla kön · Uppdaterad 2 okt. 2026 · NCT05334069

Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)

RekryterarFas 2
  • Providence Portland Medical Center, Portland
  • Providence Saint Vincent Medical Center, Portland
Ålder 18 till 59 · Alla kön · Uppdaterad 28 sep. 2026 · NCT05554393

A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)

RekryterarFas 3
  • Providence Portland Medical Center, Portland
  • Providence Oncology and Hematology Care Clinic Westside, Portland
Ålder 18 och äldre · Alla kön · Uppdaterad 25 sep. 2026 · NCT06852222

Ruxolitinib in Combination With Venetoclax With and Without Azacitidine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia

RekryterarFas 1
  • OHSU Knight Cancer Institute, Portland
Ålder 18 och äldre · Alla kön · Uppdaterad 24 sep. 2026 · NCT03874052

Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)

RekryterarFas 2
  • Providence Portland Medical Center, Portland
  • Providence Saint Vincent Medical Center, Portland
Ålder 18 till 59 · Alla kön · Uppdaterad 22 sep. 2026 · NCT05554406

Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)

RekryterarFas 2
  • Providence Portland Medical Center, Portland
  • Providence Saint Vincent Medical Center, Portland
Ålder 18 och äldre · Alla kön · Uppdaterad 22 sep. 2026 · NCT06317649

A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations

RekryterarFas 3
  • Legacy Emanuel Children's Hospital, Portland
  • Oregon Health and Science University, Portland
6 Months – 21 Years · Alla kön · Uppdaterad 17 sep. 2026 · NCT04293562

Venetoclax in Combination With Cladribine and Cytarabine Alternating With Azacitidine Plus Venetoclax for the Treatment of Newly Diagnosed Monocytic AML and Active Signaling Mutated AML

RekryterarFas 2
  • OHSU Knight Cancer Institute, Portland
Ålder 18 och äldre · Alla kön · Uppdaterad 16 sep. 2026 · NCT06504459

A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation

RekryterarFas 1/2
  • Oregon Health & Science University, Portland
30 Days · Alla kön · Uppdaterad 16 sep. 2026 · NCT04065399

Ivosidenib and Venetoclax With or Without Azacitidine in Treating Patients With IDH1 Mutated Hematologic Malignancies

RekryterarFas 1/2
  • Oregon Health and Science University, Portland
Ålder 18 och äldre · Alla kön · Uppdaterad 14 sep. 2026 · NCT03471260

Revumenib in Combination With Azacitidine + Venetoclax in Patients NPM1-mutated or KMT2A-rearranged AML

RekryterarFas 3
  • US-Portland OR-OHSU, Portland
Ålder 18 och äldre · Alla kön · Uppdaterad 2 sep. 2026 · NCT06652438

The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

RekryterarFas 1/2
  • Legacy Emanuel Children's Hospital, Portland
  • Oregon Health and Science University, Portland
Upp till ålder 22 · Alla kön · Uppdaterad 25 aug. 2026 · NCT04726241

Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)

RekryterarFas 3
  • Doernbecher Children's Hospital, Portland
29 Days – 21 Years · Alla kön · Uppdaterad 24 aug. 2026 · NCT05183035

Mocravimod as Adjunctive and Maintenance Treatment in AML Patients Undergoing Allo-HCT

RekryterarFas 3
  • Oregon Health & Science University (OHSU) - Knight Cancer Institute, Portland
Ålder 18 till 75 · Alla kön · Uppdaterad 17 juli 2026 · NCT05429632

Pemigatinib After Chemotherapy for the Treatment of Newly Diagnosed Acute Myeloid Leukemia

RekryterarFas 1
  • OHSU Knight Cancer Institute, Portland
Ålder 18 och äldre · Alla kön · Uppdaterad 14 juli 2026 · NCT04659616

Induction and Consolidation With Fludarabine, Cytarabine, Idarubicin, and Venetoclax for the Treatment of Acute Myeloid Leukemia

RekryterarFas 2
  • OHSU Knight Cancer Institute, Portland
Ålder 18 till 65 · Alla kön · Uppdaterad 13 juli 2026 · NCT07228273

Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome

RekryterarFas 2
  • Oregon Health and Science University, Portland
Ålder 18 och äldre · Alla kön · Uppdaterad 7 juli 2026 · NCT07216443

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

RekryterarObservationsstudie
  • Oregon Health & Science University/Doernbecher Children's Hospital, Portland
Alla åldrar · Alla kön · Uppdaterad 6 juli 2026 · NCT01351545

Iadademstat in Combination With Azacitidine and Venetoclax in Treating Newly Diagnosed Acute Myeloid Leukemia

RekryterarFas 1
  • OHSU Knight Cancer Institute, Portland
Ålder 18 och äldre · Alla kön · Uppdaterad 30 juni 2026 · NCT06357182

A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)

RekryterarFas 2/3
  • Oregon Health and Science University, Portland
Ålder 18 och äldre · Alla kön · Uppdaterad 30 apr. 2026 · NCT04256317

A Phase 1 Study of STX-0712 in Patients With Advanced Hematological Malignancies (CMML and AML)

RekryterarFas 1
  • OHSU, Portland
Ålder 18 och äldre · Alla kön · Uppdaterad 9 feb. 2026 · NCT06950034

Specialty Compared to Oncology Delivered Palliative Care for Patients With Acute Myeloid Leukemia

RekryterarFriska volontärer välkomna
  • Oregon Health & Science University, Portland
Ålder 18 till 120 · Alla kön · Uppdaterad 25 juli 2025 · NCT05237258

Akut myeloid leukemi-studier i andra städer

Andra studier i Portland

Från ClinicalTrials.gov, data hämtad 6 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.